InDex Pharmaceuticals Holding AB(DE:1NP1)
€1.08+-0.01 (+1.42%)
DE:1NP1
InDex Pharmaceuticals Holding AB Revenue
€1.08
At close:+-0.01 (+1.42%)
InDex Pharmaceuticals Holding AB (1NP1) Revenue
5 Followers
InDex Pharmaceuticals Holding AB Revenue
InDex Pharmaceuticals Holding AB had a revenue of 900.00K in the quarter ending Sep 30, 2026, with 212.50%. This bring the company's revenue in the last twelve months to -5.10M, Increased 75.71%. In the fiscal year ending Dec 31, 2025, InDex Pharmaceuticals Holding AB had annual revenue of 8.80M with 8700.00% growth.
- Revenue (ttm)
- -5.10M
- Revenue Growth
- -180.59%
- P/S Ratio
- 12.17
- Revenue/Employee
- EUR 1,100,000
- Employees
- 8
- Market Cap
- EUR 107.07M
Revenue Chart
InDex Pharmaceuticals Holding AB Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.80M | 8.70M | 8700.00% |
| Dec 31, 2024 | 100.00K | -97.41M | -99.90% |
| Dec 31, 2023 | 97.50M | 97.50M | ― |
| Dec 31, 2022 | 0.00 | 0.00 | ― |
| Dec 31, 2021 | 0.00 | -35.00K | -100.00% |
| Dec 31, 2020 | 35.00K | -53.00K | -60.23% |
| Dec 31, 2019 | 88.00K | -40.00K | -31.25% |
| Dec 31, 2018 | 128.00K | 15.00K | 13.27% |
| Dec 31, 2017 | 113.00K | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.